Rakesh Jhunjhunwala changes portfolio; These stocks got Big Bull's thumbs up; reason to buy?

Ace investor Rakesh Jhunjhunwala's portfolio is widely tracked by big and small stock market investors alike on Dalal Street. As the shareholding pattern for the June quarter has started pouring in, it can be seen that the Big Bull has changed his holdings in many stocks. 

Among 29 stocks where Rakesh Jhunjhunwala holds over 1 per cent stake, three saw his holdings go up. These include Lupin, NCC and Jaiprakash Associates. The man they call the 'Warren Buffett of India', has even trimmed his stake in his favourite stock Titan Company. He also sold a stakes in Dewan Housing Finance Corporation (DHFL), Crisil, Edelweiss Financial Services, Firstsource Solutions.  

Jhunjhunwala, meanwhile, maintained his holdings in Aptech, Geojit Financial Services and Ion Exchange, Man Infra Construction, MCX and VIP Industries. Shareholding patterns of many other companies of his portfolio are yet to be disclosed. 

The market guru sold some part of his stake in Titan and it has fallen from 8.46 per cent holding at the end of March quarter to 7.06 per cent now. He marginally tweaked his holdings in Crisil, Edelweiss Financial Services, Firstsource Solutions, where his stakes now stand at 5.52 per cent, 1.08 per cent and 2.90 per cent, respectively. 

The ace investor cut shareholding in DHFL to 2.76 per cent in Q1FY19, from 3.19 per cent in Q4FY18. In terms of shares, he sold 13,34,736 shares during the quarter, bringing the stake down to 86,65,264 shares at the end of June quarter from 1,00,00,000 shares earlier. 

Jhunjhunwala bought additional 1 lakh shares of the pharma major Lupin in the June quarter. He owned 86,98,605 shares or 1.92 per cent stake in Lupin at the end of the March quarter. According to latest shareholding pattern available on the BSE, Jhunjhunwala increased his holding in Lupin by 1 lakh shares in the June quarter. 

WATCH ZEE BUSINESS VIDEO HERE

The Big Bull now owns 1.95 per cent stake or 87,98,605 shares in the pharma company.

Besides, he increased his stakes in debt-laden Jaiprakash Associates to 1.98 per cent in June quarter from 1.19 per cent at the end of March quarter.